Literature DB >> 24849359

Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses.

Anne M J Verstegen1, Erica Tagliatti2, Gabriele Lignani1, Antonella Marte3, Tamar Stolero4, Merav Atias4, Anna Corradi3, Flavia Valtorta5, Daniel Gitler4, Franco Onofri3, Anna Fassio6, Fabio Benfenati2.   

Abstract

Cyclin-dependent kinase-5 (Cdk5) was reported to downscale neurotransmission by sequestering synaptic vesicles (SVs) in the release-reluctant resting pool, but the molecular targets mediating this activity remain unknown. Synapsin I (SynI), a major SV phosphoprotein involved in the regulation of SV trafficking and neurotransmitter release, is one of the presynaptic substrates of Cdk5, which phosphorylates it in its C-terminal region at Ser(549) (site 6) and Ser(551) (site 7). Here we demonstrate that Cdk5 phosphorylation of SynI fine tunes the recruitment of SVs to the active recycling pool and contributes to the Cdk5-mediated homeostatic responses. Phosphorylation of SynI by Cdk5 is physiologically regulated and enhances its binding to F-actin. The effects of Cdk5 inhibition on the size and depletion kinetics of the recycling pool, as well as on SV distribution within the nerve terminal, are virtually abolished in mouse SynI knock-out (KO) neurons or in KO neurons expressing the dephosphomimetic SynI mutants at sites 6,7 or site 7 only. The observation that the single site-7 mutant phenocopies the effects of the deletion of SynI identifies this site as the central switch in mediating the synaptic effects of Cdk5 and demonstrates that SynI is necessary and sufficient for achieving the effects of the kinase on SV trafficking. The phosphorylation state of SynI by Cdk5 at site 7 is regulated during chronic modification of neuronal activity and is an essential downstream effector for the Cdk5-mediated homeostatic scaling.
Copyright © 2014 the authors 0270-6474/14/347266-15$15.00/0.

Entities:  

Keywords:  Cdk5; actin; phosphorylation; synapsin; synaptic homeostasis; synaptic vesicle

Mesh:

Substances:

Year:  2014        PMID: 24849359      PMCID: PMC6608192          DOI: 10.1523/JNEUROSCI.3973-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Phosphorylation of adult type Sept5 (CDCrel-1) by cyclin-dependent kinase 5 inhibits interaction with syntaxin-1.

Authors:  Makoto Taniguchi; Masato Taoka; Makoto Itakura; Akiko Asada; Taro Saito; Makoto Kinoshita; Masami Takahashi; Toshiaki Isobe; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2007-01-15       Impact factor: 5.157

2.  Interference between two modulators of N-type (CaV2.2) calcium channel gating demonstrates that omega-conotoxin GVIA disrupts open state gating.

Authors:  Viktor Yarotskyy; Keith S Elmslie
Journal:  Biochim Biophys Acta       Date:  2010-05-13

3.  Cyclin-dependent kinase 5-dependent phosphorylation of Pctaire1 regulates dendrite development.

Authors:  W-Y Fu; K Cheng; A K Y Fu; N Y Ip
Journal:  Neuroscience       Date:  2011-02-16       Impact factor: 3.590

4.  The synapsin gene family in basal chordates: evolutionary perspectives in metazoans.

Authors:  Simona Candiani; Luca Moronti; Roberta Pennati; Fiorenza De Bernardi; Fabio Benfenati; Mario Pestarino
Journal:  BMC Evol Biol       Date:  2010-01-29       Impact factor: 3.260

5.  Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.

Authors:  Kai Cheng; Zhen Li; Wing-Yu Fu; Jerry H Wang; Amy K Y Fu; Nancy Y Ip
Journal:  J Biol Chem       Date:  2002-06-25       Impact factor: 5.157

6.  Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK.

Authors:  Benjamin Adam Samuels; Yi-Ping Hsueh; Tianzhi Shu; Haoya Liang; Huang-Chun Tseng; Chen-Jei Hong; Susan C Su; Janet Volker; Rachael L Neve; David T Yue; Li-Huei Tsai
Journal:  Neuron       Date:  2007-12-06       Impact factor: 17.173

Review 7.  The synapsin cycle: a view from the synaptic endocytic zone.

Authors:  E Evergren; F Benfenati; O Shupliakov
Journal:  J Neurosci Res       Date:  2007-09       Impact factor: 4.164

8.  Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity.

Authors:  Andrea Menegon; Dario Bonanomi; Chiara Albertinazzi; Francesco Lotti; Giuliana Ferrari; Hung-Teh Kao; Fabio Benfenati; Pietro Baldelli; Flavia Valtorta
Journal:  J Neurosci       Date:  2006-11-08       Impact factor: 6.167

9.  A preferentially segregated recycling vesicle pool of limited size supports neurotransmission in native central synapses.

Authors:  Vincenzo Marra; Jemima J Burden; Julian R Thorpe; Ikuko T Smith; Spencer L Smith; Michael Häusser; Tiago Branco; Kevin Staras
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

10.  Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity.

Authors:  Gabriele Lignani; Andrea Raimondi; Enrico Ferrea; Anna Rocchi; Francesco Paonessa; Fabrizia Cesca; Marta Orlando; Tatiana Tkatch; Flavia Valtorta; Patrick Cossette; Pietro Baldelli; Fabio Benfenati
Journal:  Hum Mol Genet       Date:  2013-02-12       Impact factor: 6.150

View more
  38 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

Review 2.  Functionally heterogeneous synaptic vesicle pools support diverse synaptic signalling.

Authors:  Simon Chamberland; Katalin Tóth
Journal:  J Physiol       Date:  2015-12-28       Impact factor: 5.182

Review 3.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 4.  Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.

Authors:  Kavita Shah; Sandra Rossie
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

5.  Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity.

Authors:  Barbara Calabrese; Shelley Halpain
Journal:  Mol Cell Neurosci       Date:  2015-03-27       Impact factor: 4.314

Review 6.  Bassoon and piccolo regulate ubiquitination and link presynaptic molecular dynamics with activity-regulated gene expression.

Authors:  Daniela Ivanova; Anika Dirks; Anna Fejtova
Journal:  J Physiol       Date:  2016-04-24       Impact factor: 5.182

7.  Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.

Authors:  Guangna Yu; Xingyuan Sun; Li Li; Lijuan Huang; Hongbin Liu; Shuying Wang; Zhanjun Ren; Yanjiao Zhang
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

8.  Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Authors:  Alberto Lleó; Raúl Núñez-Llaves; Daniel Alcolea; Cristina Chiva; Daniel Balateu-Paños; Martí Colom-Cadena; Gemma Gomez-Giro; Laia Muñoz; Marta Querol-Vilaseca; Jordi Pegueroles; Lorena Rami; Albert Lladó; José L Molinuevo; Mikel Tainta; Jordi Clarimón; Tara Spires-Jones; Rafael Blesa; Juan Fortea; Pablo Martínez-Lage; Raquel Sánchez-Valle; Eduard Sabidó; Àlex Bayés; Olivia Belbin
Journal:  Mol Cell Proteomics       Date:  2019-01-03       Impact factor: 5.911

9.  Functions of synapsins in corticothalamic facilitation: important roles of synapsin I.

Authors:  Maxim Nikolaev; Paul Heggelund
Journal:  J Physiol       Date:  2015-09-02       Impact factor: 5.182

10.  Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Yura Choi; Ha Jin Jeong; Quan Feng Liu; Seung Tack Oh; Byung-Soo Koo; Yeni Kim; In-Won Chung; Yong Sik Kim; Songhee Jeon
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.